|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 17.66 SEK | -0.11% |
|
-1.34% | -21.86% |
| Market Cap | 989M 98.73M 87.13M 82.44M 74.76M 140M 9.47B 142M 381M 4.84B 371M 363M 15.57B | P/E 2026 * |
-10.5x | P/E 2027 * | -18x |
|---|---|---|---|---|---|
| Enterprise Value | 1.01B 101M 89.31M 84.5M 76.64M 144M 9.71B 145M 391M 4.96B 380M 372M 15.96B | EV / Sales 2026 * |
22.9x | EV / Sales 2027 * | 49.2x |
| Free-Float |
73.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| SYNACT | Delayed | |
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 8F8 | Delayed | |
|
Börse Stuttgart
| 8F8 | Delayed | |
|
CBOE
| Real-time | ||
|
Tradegate
| 8F8 | Real-time | |
|
Boerse Muenchen
| 8F8 | Real-time |
Last Transcript: SynAct Pharma AB
| 1 day | -0.11% | ||
| 1 week | -1.34% | ||
| Current month | -11.70% | ||
| 1 month | -11.35% | ||
| 3 months | -4.02% | ||
| 6 months | -1.78% | ||
| Current year | -21.86% |
| 1 week | 17 |  | 18.06 |
| 1 month | 16.84 | | 22.45 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 25.3 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.8 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 2013-12-31 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 2026-02-28 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 2024-03-19 |
Anders Kronborg
CHM | Chairman | 62 | 2024-03-19 |
Sten Scheibye
BRD | Director/Board Member | 74 | 2024-03-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/2/26 | Sell | Founder | -150,000 | 0.2813% | ||
| 9/2/26 | Sell | Chief Technology Officer | -350,000 | 0.6563% | ||
| 3/10/26 | Buy | Chairman | 2,750 | 0.0052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.11% | -1.34% | -19.36% | -1.34% | 99.42M | |
| -0.01% | +1.24% | +63.06% | +120.55% | 1,056B | |
| -1.61% | -0.60% | +47.32% | +71.79% | 655B | |
| -1.12% | -0.72% | +17.98% | +76.63% | 471B | |
| -1.72% | -4.06% | +36.39% | +39.47% | 342B | |
| -0.40% | +3.83% | +22.08% | +28.82% | 277B | |
| -0.51% | -1.93% | +12.09% | +11.94% | 257B | |
| +1.32% | +3.27% | +54.63% | +57.63% | 226B | |
| -0.61% | -0.91% | +34.33% | +101.87% | 189B | |
| -0.24% | -2.76% | -28.41% | -60.92% | 170B | |
| Average | -0.18% | -0.04% | +24.01% | +44.64% | 364.3B | |
| Weighted average by Cap. | -0.05% | +0.42% | +38.91% | +70.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 44.25M 4.42M 3.9M 3.69M 3.35M 6.27M 424M 6.33M 17.05M 216M 16.59M 16.23M 697M | 21.6M 2.16M 1.9M 1.8M 1.63M 3.06M 207M 3.09M 8.32M 106M 8.1M 7.92M 340M |
| Net income | -47.08M -4.7M -4.15M -3.92M -3.56M -6.67M -451M -6.74M -18.15M -230M -17.65M -17.27M -741M | -31.92M -3.19M -2.81M -2.66M -2.41M -4.52M -306M -4.57M -12.3M -156M -11.97M -11.71M -502M |
| Net Debt | 24.81M 2.48M 2.19M 2.07M 1.88M 3.52M 238M 3.55M 9.56M 121M 9.3M 9.1M 391M | 74.22M 7.41M 6.54M 6.19M 5.61M 10.52M 711M 10.62M 28.6M 363M 27.82M 27.22M 1.17B |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | SEK 17.66 | -0.11% | 45,694 |
| 26-09-28 | SEK 17.68 | +2.20% | 60,968 |
| 26-09-25 | SEK 17.30 | -0.92% | 171,228 |
| 26-09-24 | SEK 17.46 | -0.57% | 55,745 |
| 26-09-23 | SEK 17.56 | -1.90% | 77,862 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Select your edition
All financial news and data tailored to specific country editions
